# Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease

> **NCT00555204** · PHASE2 · TERMINATED · sponsor: **Abbott** · enrollment: 337 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** ABT-089
- **DRUG:** ABT-089
- **DRUG:** ABT-089
- **DRUG:** ABT-089
- **DRUG:** ABT-089
- **DRUG:** ABT-089
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00555204
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2009-06
- **Final completion:** —
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2011-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555204, "Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00555204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*